Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Pediatric Asthma Treatment Market Poised To Hit $15.14 Billion By 2030 With A 5.3% CAGR
The pediatric asthma treatment market has experienced substantial expansion in recent years. This market is projected to expand from $11.65 billion in 2025 to $12.31 billion in 2026, registering a compound annual growth rate (CAGR) of 5.7%. Historically, this expansion has been driven by factors such as the restricted availability of medications specifically designed for pediatric asthma, a strong reliance on hospital-based care, the rising incidence of childhood asthma, heightened awareness among caregivers, and the widespread use of traditional inhalers and short-acting beta agonists.
The pediatric asthma treatment market is projected to experience substantial expansion over the coming years. It is anticipated to reach a valuation of $15.14 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.3%. This projected increase during the forecast period is driven by factors such as the advancement of biologics and combination therapies, the incorporation of digital health monitoring devices, the extension of home care services, growing adoption of online pharmacies, and an increase in regulatory approvals for pediatric asthma medications. Key developments expected during this period include a greater emphasis on personalized pediatric asthma treatments, increased utilization of biologic therapies and combination inhalers, a rise in home care and remote patient monitoring solutions, the broadening of online and retail pharmacy distribution channels, and a concerted focus on early diagnosis and preventive asthma management.
Get A Free Sample Report With In-Depth Market Insights:
Pediatric Asthma Treatment Market Growth Drivers: What’s Behind The Acceleration?
The rising occurrence of respiratory infections is projected to stimulate the growth of the pediatric asthma treatment market moving forward. Respiratory infections are defined as illnesses originating from viruses, bacteria, or other pathogens affecting the respiratory tract, encompassing the nose, throat, airways, and lungs. The growing prevalence of respiratory infections is primarily attributed to increasing air pollution, given that exposure to pollutants such as particulate matter and nitrogen dioxide compromises the respiratory system, rendering individuals more prone to infections. Pediatric asthma treatment assists in diminishing the frequency and severity of respiratory infections by improving airway function and reducing inflammation, which in turn lowers susceptibility to infectious triggers. For instance, in June 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, in 2023, chronic obstructive pulmonary disease contributed to 3.6% of the total disease burden and represented 50% of the total burden of respiratory conditions. Consequently, the increasing prevalence of respiratory infections drives the expansion of the pediatric asthma treatment market.
Pediatric Asthma Treatment Market Segment Landscape And Growth Outlook
The pediatric asthma treatment market covered in this report is segmented –
1) By Type: Long-Term Control Medications, Quick-Relief Medications, Other Types
2) By Drug Class: Inhaled Corticosteroids, Long-Acting Beta Agonists, Leukotriene Modifiers, Antihistamines, Biologics
3) By Route Of Administration: Oral Route, Nasal Route, Injectable Route
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End User: Hospitals, Clinics, Home Care, Other End users
Subsegments:
1) By Long-Term Control Medications: Inhaled Corticosteroids, Leukotriene Modifiers, Long-Acting Beta Agonists, Combination Inhalers, Biologic Therapies
2) By Quick-Relief Medications: Short-Acting Beta Agonists, Anticholinergics, Systemic Corticosteroids
3) By Other Types: Immunotherapy, Methylxanthines, Alternative Therapies
Pediatric Asthma Treatment Market Trends: What’s Defining The Industry’s Next Phase?
Major companies in the pediatric asthma treatment market are concentrating on developing innovative therapies, such as monoclonal antibodies, to target and reduce airway inflammation in children. Monoclonal antibodies are laboratory-made proteins designed to mimic the immune system’s ability to fight off harmful pathogens by specifically targeting certain cells or substances. For instance, in April 2024, AstraZeneca PLC, a UK-based pharmaceutical and biotechnology company, received U.S. Food and Drug Administration approval for FASENRA (benralizumab) as an add-on maintenance treatment for children aged 6 to 11 years with severe asthma characterized by an eosinophilic phenotype. This antibody is designed to reduce asthma exacerbations and improve symptom control by targeting and eliminating eosinophils. Fasenra is administered via subcutaneous injection once every 4 weeks for the first three doses, followed by once every 8 weeks, with pediatric dosing adjusted based on body weight.
Pediatric Asthma Treatment Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the pediatric asthma treatment market are Pfizer Inc., Merck And Co Inc., Novartis AG, Sanofi S.A., AstraZeneca plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Limited, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Genentech Inc., Chiesi Farmaceutici S.p.A, Dr. Reddy’s Laboratories Ltd, Cipla Ltd, Lupin Limited, Zydus Lifesciences Ltd.
View The Full Pediatric Asthma Treatment Market Report:
Pediatric Asthma Treatment Market Geographic Landscape: Which Region Leads Industry Growth?
North America was the largest region in the pediatric asthma treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pediatric asthma treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
